MedTrace Logo

Therapeutic Plasma Exchange in Thyrotoxicosis

NCT04485975 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2020-07-24

No results posted yet for this study

Summary

Therapeutic plasma exchange (TPE) is indicated in cases where antithyroid medications cannot be used due to the side effects or attain no adequate hormonal suppression response at the highest dosage and in cases of rapid onset of clinical symptoms. This study presents the treatment results of patients who underwent TPE and subsequently operated for thyrotoxicosis.

Conditions

  • Thyrotoxicosis

Interventions

DEVICE

Therapeutic plasma exchange

Therapeutic plasma exchange filtrates plasma and decreases thyroid hormone concentration in the blood

Sponsors & Collaborators

  • Baskent University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-01-01
Primary Completion
2019-02-01
Completion
2020-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04485975 on ClinicalTrials.gov